Imunon Inc (IMNN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.85M
Last updated: Nov 17, 2026 at 4:15 PM ET
Imunon Inc (IMNN) Stock Chart
Imunon (IMNN) has a latest price of $0.61 on Nov 17, 2026, 86.0% below its 52-week high of $4.35. Its price fell 85.5% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 55.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $3,274.35 in Oct 2016 and its lowest $0.91 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IMNN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IMNN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 61.4%, and over 6 months it fell 72.6%. The month-end price fell 93.9% over the 3 years through Oct 2026, a compound annual decline of 60.6%.
| Period | Change |
|---|---|
| 1 month | -38.1% |
| 3 months | -61.4% |
| 6 months | -72.6% |
| 12 months | -85.5% |
| 12 months, with dividends | -85.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -93.9% | -60.6% |
| 5 years | -99.6% | -66.1% |
| 10 years | -100.0% | -55.9% |
Price by Year
Its best calendar year was 2024, when the price rose 39.7%, and its weakest was 2022, when it fell 83.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.91 | -76.1% |
| 2025 | $3.81 | -73.2% |
| 2024 | $14.24 | +39.7% |
| 2023 | $10.19 | -49.6% |
| 2022 | $20.24 | -83.3% |
| 2021 | $121.38 | -24.1% |
| 2020 | $159.82 | -58.4% |
| 2019 | $384.37 | +21.3% |
| 2018 | $316.93 | -47.4% |
| 2017 | $602.40 | -37.0% |
Trading Range
The price is 45.3% below its 50-day average of $1.11 and 70.6% below its 200-day average of $2.07.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.61 | |
| 52-week high | $4.35 | -86.0% |
| 52-week low | $0.49 | +23.3% |
| 50-day average | $1.11 | -45.3% |
| 200-day average | $2.07 | -70.6% |
Price Risk
Over 3 years, its largest fall from a peak was 98.6%.
| Measure | Value |
|---|---|
| 1-year beta | 0.49 |
| Largest fall, 1 year | -85.8% |
| Largest fall, 3 years | -98.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IMNN
What is IMNN's 1-year price change?
Imunon's price fell 85.5% over the past 12 months. With dividends included, the 12-month total return was -85.5%.
What is IMNN's 5-year price change?
Imunon's month-end price fell 99.6% over the 5 years through Oct 2026, a compound annual decline of 66.1%. These figures leave out dividends.
What is IMNN's 52-week high and low?
Imunon's 52-week high is $4.35 and its 52-week low is $0.49. Its latest price of $0.61 on Nov 17, 2026 is 86.0% below the high.
What is IMNN's beta?
Imunon's 1-year beta against the S&P 500 is 0.49, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 85.8%.
Is the IMNN chart free?
Yes. Advanced Charting for IMNN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IMNN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors